Skip to main content
Erschienen in:

07.12.2018 | Clinical Study

Etiology and prognosis of acute respiratory failure in patients with primary malignant brain tumors admitted to the intensive care unit

verfasst von: Maxens Decavèle, Isabelle Rivals, Clémence Marois, Marie Cantier, Nicolas Weiss, Léa Lemasle, Hélène Prodanovic, Khe Hoang-Xuan, Ahmed Idbaih, Thomas Similowski, Alexandre Demoule

Erschienen in: Journal of Neuro-Oncology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Acute respiratory failure (ARF) is common and potentially fatal in patients with primary malignant brain tumors (PMBT). However, few data are available regarding its precipitating factors and prognosis. We sought to: (1) compare the causes of ARF and the outcome between patients with PMBT and patients with other peripheral solid tumors (PST), (2) identify the factors influencing ICU survival in PMBT patients.

Methods

Two-center retrospective case-control study from March 1996 to May 2014. Primary central nervous system lymphomas were also included.

Results

Eighty-four patients with PMBT and 133 patients with PST were included. Acute infectious pneumonia was more frequent in PMBT than PST patients (77 vs. 36%, p < 0.001). Pulmonary embolism was also more frequent in PMBT patients (13% vs. 5%, p = 0.042), while cardiogenic pulmonary edema and acute-on-chronic respiratory failure were more frequent in PST patients (37 vs. 10%, p < 0.001). Among acute infectious pneumonia, Pneumocystis pneumonia and aspiration pneumonia were more frequent in PMBT patients (19 vs. 2%, p < 0.001 and 19 vs. 8%, p < 0.001, respectively). ICU mortality was similar between PMBT and PST patients (24% vs. 24%, p = 0.966). In multivariate analysis, cancer progression (OR 7.25 95% CI 1.13–46.45, p = 0.034), need for intubation (OR 7.01 95% CI 1.29–38.54, p = 0.022), were independently associated with ICU mortality in PMBT patients.

Conclusions

The cause of ARF in patients with PMBT differs significantly than those with PST and up to 50% may have been prevented. Mortality did not differ between the two groups. These results suggest that PMBT alone is not a relevant criterion for ICU recusal.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Azoulay E, Thiéry G, Chevret S et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360–370CrossRef Azoulay E, Thiéry G, Chevret S et al (2004) The prognosis of acute respiratory failure in critically ill cancer patients. Medicine (Baltimore) 83:360–370CrossRef
2.
Zurück zum Zitat Azoulay E, Mokart D, Pène F, Schlemmer B, Chevret S, Lemiale V (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31:2810–2818CrossRefPubMed Azoulay E, Mokart D, Pène F, Schlemmer B, Chevret S, Lemiale V (2013) Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study. J Clin Oncol 31:2810–2818CrossRefPubMed
3.
Zurück zum Zitat Azoulay E, Lemiale V, Mokart D et al (2014) Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 40:1106–1114CrossRefPubMed Azoulay E, Lemiale V, Mokart D et al (2014) Acute respiratory distress syndrome in patients with malignancies. Intensive Care Med 40:1106–1114CrossRefPubMed
4.
Zurück zum Zitat Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808–822CrossRefPubMed Azoulay E, Schlemmer B (2006) Diagnostic strategy in cancer patients with acute respiratory failure. Intensive Care Med 32:808–822CrossRefPubMed
5.
Zurück zum Zitat Tabouret E, Boucard C, Devillier R, Barrie M, Boussen S, Autran D, Chinot O, Bruder N (2016) Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome. J Neurooncol 127:111–117CrossRefPubMed Tabouret E, Boucard C, Devillier R, Barrie M, Boussen S, Autran D, Chinot O, Bruder N (2016) Neuro-oncological patients admitted in intensive-care unit: predictive factors and functional outcome. J Neurooncol 127:111–117CrossRefPubMed
6.
Zurück zum Zitat Decavèle M, Weiss N, Rivals I et al (2017) Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience. J Neurol 264:2303–2312CrossRefPubMed Decavèle M, Weiss N, Rivals I et al (2017) Prognosis of patients with primary malignant brain tumors admitted to the intensive care unit: a two-decade experience. J Neurol 264:2303–2312CrossRefPubMed
7.
Zurück zum Zitat Mahindra AK, Grossman SA (2003) Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors. J Neurooncol 63:263–270CrossRefPubMed Mahindra AK, Grossman SA (2003) Pneumocystis carinii pneumonia in HIV negative patients with primary brain tumors. J Neurooncol 63:263–270CrossRefPubMed
8.
Zurück zum Zitat Wesling M, Brady S, Jensen M, Nickell M, Statkus D, Escobar N (2013) Dysphagia outcomes in patients with brain tumors undergoing inpatient rehabilitation. Dysphagia 18:203–210 Wesling M, Brady S, Jensen M, Nickell M, Statkus D, Escobar N (2013) Dysphagia outcomes in patients with brain tumors undergoing inpatient rehabilitation. Dysphagia 18:203–210
9.
Zurück zum Zitat Lee WH, Oh BM, Seo HG et al (2016) One-year outcome of postoperative swallowing impairment in pediatric patients with posterior fossa brain tumor. J Neurooncol 127:73–81CrossRefPubMed Lee WH, Oh BM, Seo HG et al (2016) One-year outcome of postoperative swallowing impairment in pediatric patients with posterior fossa brain tumor. J Neurooncol 127:73–81CrossRefPubMed
10.
Zurück zum Zitat Mokart D, Lambert J, Schnell D et al (2013) Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 54:1724–1729CrossRefPubMed Mokart D, Lambert J, Schnell D et al (2013) Delayed intensive care unit admission is associated with increased mortality in patients with cancer with acute respiratory failure. Leuk Lymphoma 54:1724–1729CrossRefPubMed
11.
Zurück zum Zitat Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRefPubMed Louis DN, Perry A, Reifenberger G et al (2016) The 2016 World Health Organization classification of tumors of the central nervous system: a summary. Acta Neuropathol 131:803–820CrossRefPubMed
12.
Zurück zum Zitat Vaquero J, Martínez R, Manrique M (2000) Stereotactic biopsy for brain tumors: is it always necessary? Surg Neurol 53:432–437CrossRefPubMed Vaquero J, Martínez R, Manrique M (2000) Stereotactic biopsy for brain tumors: is it always necessary? Surg Neurol 53:432–437CrossRefPubMed
13.
Zurück zum Zitat Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed Oken MM, Creech RH, Tormey DC et al (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5:649–655CrossRefPubMed
14.
Zurück zum Zitat Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251CrossRefPubMed Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251CrossRefPubMed
15.
Zurück zum Zitat Le Gall JR, Lemeshow S, Saulnier FA (1993) New simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963CrossRefPubMed Le Gall JR, Lemeshow S, Saulnier FA (1993) New simplified acute physiology score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963CrossRefPubMed
16.
Zurück zum Zitat Vincent JL, Moreno R, Takala J et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of intensive care medicine. Intensive Care Med 22:707–710CrossRefPubMed Vincent JL, Moreno R, Takala J et al (1996) The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the working group on sepsis-related problems of the European Society of intensive care medicine. Intensive Care Med 22:707–710CrossRefPubMed
17.
Zurück zum Zitat Gea-Banacloche JC, Opal SM, Jorgensen J, Carcillo JA, Sepkowitz KA, Cordonnier C (2004) Sepsis associated with immunosuppressive medications: an evidence-based review. Crit Care Med 32:S578–S590CrossRefPubMed Gea-Banacloche JC, Opal SM, Jorgensen J, Carcillo JA, Sepkowitz KA, Cordonnier C (2004) Sepsis associated with immunosuppressive medications: an evidence-based review. Crit Care Med 32:S578–S590CrossRefPubMed
18.
Zurück zum Zitat Ferreri AJ, Reni M, Foppoli M et al (2009) High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374:1512–1520CrossRefPubMed Ferreri AJ, Reni M, Foppoli M et al (2009) High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 374:1512–1520CrossRefPubMed
19.
Zurück zum Zitat Wolach O, Bairey O, Lahav M (2010) Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine (Baltimore) 2010 89:308–318CrossRef Wolach O, Bairey O, Lahav M (2010) Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature. Medicine (Baltimore) 2010 89:308–318CrossRef
20.
Zurück zum Zitat Schiff D (1996) Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features. J Neurooncol 27:235–240CrossRefPubMed Schiff D (1996) Pneumocystis pneumonia in brain tumor patients: risk factors and clinical features. J Neurooncol 27:235–240CrossRefPubMed
21.
Zurück zum Zitat Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AO (1991) Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48:406–409CrossRefPubMed Henson JW, Jalaj JK, Walker RW, Stover DE, Fels AO (1991) Pneumocystis carinii pneumonia in patients with primary brain tumors. Arch Neurol 48:406–409CrossRefPubMed
22.
Zurück zum Zitat Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:5–13CrossRefPubMed Yale SH, Limper AH (1996) Pneumocystis carinii pneumonia in patients without acquired immunodeficiency syndrome: associated illness and prior corticosteroid therapy. Mayo Clin Proc 71:5–13CrossRefPubMed
23.
Zurück zum Zitat Hughes MA, Parisi M, Grossman S, Kleinberg L (2005) Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 62:1423–1426CrossRefPubMed Hughes MA, Parisi M, Grossman S, Kleinberg L (2005) Primary brain tumors treated with steroids and radiotherapy: low CD4 counts and risk of infection. Int J Radiat Oncol Biol Phys 62:1423–1426CrossRefPubMed
24.
Zurück zum Zitat Sengupta S, Marrinan J, Frishman C, Sampath P (2012) Impact of temozolomide on immune response during malignant glioma chemotherapy. Clin Dev Immunol 2012:831090 Sengupta S, Marrinan J, Frishman C, Sampath P (2012) Impact of temozolomide on immune response during malignant glioma chemotherapy. Clin Dev Immunol 2012:831090
25.
Zurück zum Zitat Lin AJ, Campian JL, Hui C et al (2018) Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy. J Neurooncol 136:403–411CrossRefPubMed Lin AJ, Campian JL, Hui C et al (2018) Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy. J Neurooncol 136:403–411CrossRefPubMed
26.
Zurück zum Zitat Leff RL, Mckenzie R (1990) Rheumatoid arthritis, methotrexate therapy and Pneumocystis pneumonia. Ann Intern Med 112:116CrossRef Leff RL, Mckenzie R (1990) Rheumatoid arthritis, methotrexate therapy and Pneumocystis pneumonia. Ann Intern Med 112:116CrossRef
27.
Zurück zum Zitat Park DH, Chun MH, Lee SJ, Song YB (2013) Comparison of swallowing functions between brain tumor and stroke patients. Ann Rehabil Med 37:633–641CrossRefPubMedPubMedCentral Park DH, Chun MH, Lee SJ, Song YB (2013) Comparison of swallowing functions between brain tumor and stroke patients. Ann Rehabil Med 37:633–641CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Wadhwa R, Toms J, Chittiboina P et al (2014) Dysphagia following posterior fossa surgery in adults. World Neurosurg 82:822–827CrossRefPubMed Wadhwa R, Toms J, Chittiboina P et al (2014) Dysphagia following posterior fossa surgery in adults. World Neurosurg 82:822–827CrossRefPubMed
29.
Zurück zum Zitat Lind CD (2003) Dysphagia evaluation and treatment. Gastroenterol Clin N Am 32:553–575CrossRef Lind CD (2003) Dysphagia evaluation and treatment. Gastroenterol Clin N Am 32:553–575CrossRef
30.
Zurück zum Zitat Wrensch M, Minn Y, Chew T et al (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278–299CrossRefPubMedPubMedCentral Wrensch M, Minn Y, Chew T et al (2002) Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 4:278–299CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Petterson TM, Marks RS, Ashrani AA et al (2015) Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res 135:472–478CrossRefPubMed Petterson TM, Marks RS, Ashrani AA et al (2015) Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res 135:472–478CrossRefPubMed
32.
Zurück zum Zitat Semrad TJ, O’Donnell R, Wun T et al (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106:601–608CrossRefPubMed Semrad TJ, O’Donnell R, Wun T et al (2007) Epidemiology of venous thromboembolism in 9489 patients with malignant glioma. J Neurosurg 106:601–608CrossRefPubMed
33.
Zurück zum Zitat Sartori MT, Della Puppa A, Ballin A et al (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 104:225–231CrossRefPubMed Sartori MT, Della Puppa A, Ballin A et al (2011) Prothrombotic state in glioblastoma multiforme: an evaluation of the procoagulant activity of circulating microparticles. J Neurooncol 104:225–231CrossRefPubMed
34.
Zurück zum Zitat Nalluri SR, Chu D, Keresztes R et al (2008) Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 300:2277–2285CrossRefPubMed Nalluri SR, Chu D, Keresztes R et al (2008) Risk of venous thromboembolism with the angiogenesis inhibitor bevacizumab in cancer patients: a meta-analysis. JAMA 300:2277–2285CrossRefPubMed
35.
Zurück zum Zitat Green H, Paul M, Vidal L, Leibovici L (2007) Prophylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82:1052–1059CrossRefPubMed Green H, Paul M, Vidal L, Leibovici L (2007) Prophylaxis of pneumocystis pneumonia in immunocompromised non-HIV-infected patients: systematic review and meta-analysis of randomized controlled trials. Mayo Clin Proc 82:1052–1059CrossRefPubMed
36.
Zurück zum Zitat Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G, ESMO Guidelines Working Group.(2014) High-grade glioma ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25:93–101CrossRef Stupp R, Brada M, van den Bent MJ, Tonn JC, Pentheroudakis G, ESMO Guidelines Working Group.(2014) High-grade glioma ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 25:93–101CrossRef
37.
Zurück zum Zitat Hoang-Xuan K, Bessell E, Bromberg J et al (2015) European association for Neuro-Oncology task force on primary CNS lymphoma. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European association for Neuro-Oncology. Lancet Oncol 16:e322–e332CrossRefPubMed Hoang-Xuan K, Bessell E, Bromberg J et al (2015) European association for Neuro-Oncology task force on primary CNS lymphoma. Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European association for Neuro-Oncology. Lancet Oncol 16:e322–e332CrossRefPubMed
38.
Zurück zum Zitat Lyman GH, Bohlke K, Khorana AA et al (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline Update 2014. J Clin Oncol 33:654–656CrossRefPubMedPubMedCentral Lyman GH, Bohlke K, Khorana AA et al (2015) Venous thromboembolism prophylaxis and treatment in patients with cancer: american society of clinical oncology clinical practice guideline Update 2014. J Clin Oncol 33:654–656CrossRefPubMedPubMedCentral
39.
Zurück zum Zitat Dennis MS, Lewis SC, Warlow C (2005) FOOD Trial Collaboration: Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 365:764–772CrossRefPubMed Dennis MS, Lewis SC, Warlow C (2005) FOOD Trial Collaboration: Effect of timing and method of enteral tube feeding for dysphagic stroke patients (FOOD): a multicentre randomised controlled trial. Lancet 365:764–772CrossRefPubMed
40.
Zurück zum Zitat Troche MS, Okun MS, Rosenbek JC et al (2010) Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology 75:1912–1919CrossRefPubMedPubMedCentral Troche MS, Okun MS, Rosenbek JC et al (2010) Aspiration and swallowing in Parkinson disease and rehabilitation with EMST: a randomized trial. Neurology 75:1912–1919CrossRefPubMedPubMedCentral
Metadaten
Titel
Etiology and prognosis of acute respiratory failure in patients with primary malignant brain tumors admitted to the intensive care unit
verfasst von
Maxens Decavèle
Isabelle Rivals
Clémence Marois
Marie Cantier
Nicolas Weiss
Léa Lemasle
Hélène Prodanovic
Khe Hoang-Xuan
Ahmed Idbaih
Thomas Similowski
Alexandre Demoule
Publikationsdatum
07.12.2018
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 1/2019
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-018-03074-y

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

„Wir wollen die Bedeutung von Gen- und Umwelteinflüssen besser verstehen“

Eine Mutation in einem einzelnen Gen kann bei Mäusen eine Art Bipolarstörung auslösen. PD Dr. Jan Deussing vom Max-Planck-Institut für Psychiatrie in München sieht in solchen Tiermodellen eine Möglichkeit, den Ursachen der Erkrankung auf den Grund zu gehen.

Suizidassistenz erhöht Suizidzahlen: Aktuelle Ergebnisse der geplanten S3-Leitlinie

Erstmals wird in Deutschland eine S3-Leitlinie zum Thema Suizidalität erarbeitet. Ziel ist es, die Versorgung in suizidalen Krisen durch einheitliche Standards zu verbessern. Erste Ergebnisse der bisherigen Leitlinienarbeit wurden auf dem DGPPN-Kongress vorgestellt.

Kaum Vorteile durch intraarterielle Lyse während Thrombektomie

Nach der Thrombektomie kleinere Fragmente über eine intraarterielle Lyse auflösen – dies könnte die Schlaganfalltherapie verbessern. Zwei aktuelle Studien ergeben für die periprozedurale Lyse jedoch keine großen Vorteile. Die Frage, wie viel sie nützt, bleibt weiter offen.

Nasenstimulation lindert chronische Migräne

Wird die Naseninnenseite durch Vibrationen stimuliert, kann dies offenbar die Zahl der Migränetage von Menschen mit chronischer Migräne deutlich senken. Darauf deuten die Resultate einer randomisiert-kontrollierten deutsch-finnischen Untersuchung.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.